The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT06116357

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06116357
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06116357. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-01 (anticipated); primary completion 2026-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble
Condition
Primary Hypertension
Intervention (Device)
External Ultrasonic Micro-bubble
Lead sponsor
Jing Huang (class: other)
Collaborator
The Second Affiliated Hospital of Chongqing Medical University (class: other)

Record details

Record id
cardio:ct-nct06116357
Content hash
defd3d02cebac89902feed329b9a73ab66eeddec9dd8e847d3258377f3bc5764